Fundraising FoxHbvtech
2 known investors
Find your way into Hbvtech
Sign up to see every warm intro you have to Hbvtech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hbvtech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HBVtech develops a gene therapy platform intended to treat chronic infections with a single injection. Its lead program targets chronic hepatitis B (cHBV) infections, aiming for a lasting cure through one administration.
Investors · 2
Frequently asked questions
- What does Hbvtech do?
- HBVtech develops a gene therapy platform intended to treat chronic infections with a single injection. Its lead program targets chronic hepatitis B (cHBV) infections, aiming for a lasting cure through one administration.
- Who are Hbvtech's investors?
- Hbvtech's investors include Maryland TEDCO, TEDCO.